Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis

Y Komaki, A Yamada, F Komaki, P Kudaravalli… - Journal of …, 2017 - Elsevier
Objective To evaluate the efficacy and safety of biosimilars of anti-tumor necrosis factor
(TNF)-α agents compared to their reference agents in immune mediated diseases. Methods …
被引用次数：65 相关文章

Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis

Y Komaki, A Yamada, F Komaki, P Kudaravalli… - Journal of …, 2017 - infona.pl
To evaluate the efficacy and safety of biosimilars of anti-tumor necrosis factor (TNF)-α agents
compared to their reference agents in immune mediated diseases. Electronic databases …

Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.

Y Komaki, A Yamada, F Komaki… - Journal of …, 2017 - europepmc.org
Objective To evaluate the efficacy and safety of biosimilars of anti-tumor necrosis factor
(TNF)-α agents compared to their reference agents in immune mediated diseases. Methods …

Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis

Y Komaki, A Yamada, F Komaki… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of biosimilars of anti-tumor necrosis factor
(TNF)-α agents compared to their reference agents in immune mediated diseases. Methods …